Singapore markets closed

PFE Jan 2024 45.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
8.550.00 (0.00%)
As of 02:53PM EST. Market open.
Full screen
Previous close8.55
Open8.42
Bid0.00
Ask0.00
Strike45.00
Expiry date2024-01-19
Day's range8.42 - 8.55
Contract rangeN/A
Volume5
Open interest4.21k
  • Motley Fool

    Moderna Stock: Buy, Sell, or Hold in 2023?

    Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.

  • Motley Fool

    Why Pfizer Stock Is a Surefire Winner in 2023

    Pharmaceutical giant Pfizer (NYSE: PFE) is no stranger to investors; the company is a longtime staple in the healthcare industry. It got a lift in late 2020 and in 2021 as one of the COVID-19 vaccine suppliers, but investors seem to have grown bored with Pfizer's story, and the stock is down about 16% since the start of 2022. The thing is, investors shouldn't be so quick to write off Pfizer stock.

  • Zacks

    Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL

    The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.